These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34106657)
1. National early warning score on admission as risk factor for invasive mechanical ventilation in COVID-19 patients: A STROBE-compliant study. Chang MC; Kim TU; Park D Medicine (Baltimore); 2021 May; 100(19):e25917. PubMed ID: 34106657 [TBL] [Abstract][Full Text] [Related]
2. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation. Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601 [TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
4. A Machine Learning Prediction Model of Respiratory Failure Within 48 Hours of Patient Admission for COVID-19: Model Development and Validation. Bolourani S; Brenner M; Wang P; McGinn T; Hirsch JS; Barnaby D; Zanos TP; J Med Internet Res; 2021 Feb; 23(2):e24246. PubMed ID: 33476281 [TBL] [Abstract][Full Text] [Related]
5. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study. Regina J; Papadimitriou-Olivgeris M; Burger R; Le Pogam MA; Niemi T; Filippidis P; Tschopp J; Desgranges F; Viala B; Kampouri E; Rochat L; Haefliger D; Belkoniene M; Fidalgo C; Kritikos A; Jaton K; Senn L; Bart PA; Pagani JL; Manuel O; Lhopitallier L PLoS One; 2020; 15(11):e0240781. PubMed ID: 33186355 [TBL] [Abstract][Full Text] [Related]
7. Early predictors for mechanical ventilation in COVID-19 patients. Li W; Lin F; Dai M; Chen L; Han D; Cui Y; Pan P Ther Adv Respir Dis; 2020; 14():1753466620963017. PubMed ID: 33054630 [TBL] [Abstract][Full Text] [Related]
8. [Prognosis of patients with COVID-19 admitted to a tertiary center in Chile: A cohort study]. Araujo M; Ossandón P; Abarca AM; Menjiba AM; Muñoz AM Medwave; 2020 Nov; 20(10):e8066. PubMed ID: 33361751 [TBL] [Abstract][Full Text] [Related]
9. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765 [TBL] [Abstract][Full Text] [Related]
10. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
11. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak. Wang Z; Wang Z BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706 [TBL] [Abstract][Full Text] [Related]
12. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial. Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363 [TBL] [Abstract][Full Text] [Related]
13. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638 [TBL] [Abstract][Full Text] [Related]
14. Comorbidities and clinical features related to severe outcomes among COVID-19 cases in Selangor, Malaysia. Hasani WSR; Ganapathy SS; Lin CZ; Rifin HM; Bahari MN; Ghazali MH; Lodz NA; Ramli MHT; Majid NLA; Ling MYJ; Yusoff MFM; Ahmad NA; Suleiman A; Yusoff AF; Balan V; Ngadiman S Western Pac Surveill Response J; 2021; 12(1):46-52. PubMed ID: 34094624 [TBL] [Abstract][Full Text] [Related]
15. Predictors of mechanical ventilation for COVID-19: combined data from three designated hospitals. Chen J; Zhu YF; Du ZQ; Li WF; Zhang MJ; Zhao SD; Ying JW; Li Z; Miao HJ Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13065-13071. PubMed ID: 33378060 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849 [TBL] [Abstract][Full Text] [Related]
17. Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs. Vernaz N; Agoritsas T; Calmy A; Gayet-Ageron A; Gold G; Perrier A; Picard F; Prendki V; Reny JL; Samer C; Stirnemann J; Vetter P; Zanella MC; Zekry D; Baggio S Swiss Med Wkly; 2020 Dec; 150():w20446. PubMed ID: 33382449 [TBL] [Abstract][Full Text] [Related]
18. A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality. Serin I; Sari ND; Dogu MH; Acikel SD; Babur G; Ulusoy A; Onar MI; Gokce EC; Altunok O; Yaylaci Mert F; Karakilic A; Baltik M; Gulesir B J Infect Public Health; 2020 Nov; 13(11):1664-1670. PubMed ID: 33071210 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study. Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A; Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674 [TBL] [Abstract][Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]